Cy3-UTP ÒÖÖÆ¼Á BMPO Leukotriene D4 Ó«¹âȾÁÏ DMAPP ¶¨ÖƺϳÉ
(S)-»ª·¨ÁÖÖÐÎıðÃû£º»ª·¨ÁÖSÒì¹¹ÌåÔÓÖÊ;S-ÎÄÀ·¨ÐÁ;±¡ÑªÍè;S-(-)-»ª·¨ÁÖ;(-)-WARFARIN
1¡¢(S)-»ª·¨ÁÖÐÁÎïÀí»¯Ñ§ÐÔÖÊ£º
2-8¡æ ±Ü¹â£¬ÒõÁ¹¸ÉÔï´¦£¬ÃÜ·â±£´æ
³£Î³£Ñ¹ÏÂÎȶ¨
1¡¢ Ħ¶ûÕÛÉäÂÊ£º84.44
2¡¢ Ħ¶ûÌå»ý£¨m3/mol£©£º235.7
3¡¢ µÈÕűÈÈÝ£¨90.2K£©£º652.4
4¡¢ ±íÃæÕÅÁ¦£¨dyne/cm£©£º58.6
5¡¢ ¼«»¯ÂÊ£¨10 -24cm 3£©£º33.47
1¡¢ ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©£º2.7
2¡¢ Çâ¼ü¹©ÌåÊýÁ¿£º1
3¡¢ Çâ¼üÊÜÌåÊýÁ¿£º4
4¡¢ ¿ÉÐýת»¯Ñ§¼üÊýÁ¿£º4
5¡¢ »¥±äÒì¹¹ÌåÊýÁ¿£º
6¡¢ ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý£¨TPSA£©£º63.6
7¡¢ ÖØÔ×ÓÊýÁ¿£º23
8¡¢ ±íÃæµçºÉ£º0
9¡¢ ¸´ÔÓ¶È£º502
10¡¢ Í¬Î»ËØÔ×ÓÊýÁ¿£º0
11¡¢ È·¶¨Ô×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º0
12¡¢ ²»È·¶¨Ô×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º1
13¡¢ È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0
14¡¢ ²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0
15¡¢ ¹²¼Û¼üµ¥ÔªÊýÁ¿£º1
2¡¢(S)-»ª·¨ÁÖÉú̬ѧÊý¾Ý£º
¸ÃÎïÖʶԻ·¾³¿ÉÄÜÓÐΣº¦£¬¶ÔË®ÌåÓ¦¸øÓèÌØ±ð×¢Òâ¡£
3¡¢(S)-»ª·¨ÁÖÐÔÖÊÓëÎȶ¨ÐÔ£º
³£Î³£Ñ¹ÏÂÎȶ¨¡£
4¡¢(S)-»ª·¨ÁÖ·Ö×ӽṹÊý¾Ý£º
£¨1£©Ä¦¶ûÕÛÉäÂÊ£º84.44
£¨2£© Ħ¶ûÌå»ý£¨m3/mol£©£º235.7
£¨3£© µÈÕűÈÈÝ£¨90.2K£©£º652.4
£¨4£©±íÃæÕÅÁ¦£¨dyne/cm£©£º58.6
£¨5£©¼«»¯ÂÊ£¨10-24cm3£©£º33.47
5¡¢(S)-»ª·¨ÁÖÖü´æ·½·¨£º
6¡¢(S)-»ª·¨ÁÖÓÃ;£º
(S)-Warfarin is a more potent enantiomer of Warfarin as a vitamin K antagonist, anticoagulant.
7¡¢(S)-»ª·¨Áֲο¼ÎÄÏ×£º
Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes.
J. Thromb. Haemost. 8(12) , 2708-17, (2010)
Secreted protein profile from HepG2 cells incubated by S(-) and R(+) enantiomers of chiral drug warfarin - An analysis in cell-based system and clinical samples.
Proteomics. Clin. Appl. 4(10-11) , 808-15, (2010)
Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.
Hum. Gene Ther. 20(9) , 975-88, (2009)
8¡¢(S)-»ª·¨ÁÖÓ¢ÎıðÃû£º
400-186-1816
ÖÜÒ»ÖÁÖÜÎ壺8:30-17:30
¹ú¼Ò·¨¶¨½Ú¼ÙÈÕ³ýÍâ
±¾ÍøÕ¾ÏúÊÛµÄËùÓвúÆ·½öÓÃÓÚ¿ÆÑеȷÇÒ½ÁÆÓÃ;£¬·ÇÒ©Æ·²»¿ÉʳÓ㬲»¿ÉÓÃÓÚÈËÌå»ò¶¯ÎïµÄÁÙ´²Õï¶ÏºÍÖÎÁÆ¡£ÎÒÃDz»Îª¸öÈËÌṩ²úÆ·¼°·þÎñ¡£
Copyright © 2020-2025 MedBio All Rights Reserved ÉϺ£Âö²¬Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
Ñϸñ½ûÖ¹ÔÚδ¾Í¬ÒâµÄÇé¿öÏÂ×ªÔØ±¾ÍøÕ¾Ö®ËùÓÐÐÅÏ¢¡£ÈçÐèÊÚȨ£¬ÇëÁªÏµÎÒ˾¡£
»¦¹«Íø°²±¸ 31011402010197ºÅ | | »¦ICP±¸2020034979ºÅ
MedBio¿Í·þ1
MedBio¿Í·þ2
MedBio¿Í·þ3
MedBio¿Í·þ4
MedBio¿Í·þ5
MedBio¿Í·þ6